These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31285853)

  • 21. HDAC inhibitor-induced activation of NF-κB prevents apoptotic response of E1A+Ras-transformed cells to proapoptotic stimuli.
    Abramova MV; Zatulovskiy EA; Svetlikova SB; Pospelov VA
    Int J Biochem Cell Biol; 2010 Nov; 42(11):1847-55. PubMed ID: 20692358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus E1A gene-induced tumor cell rejection through cellular sensitization to immune and nonimmune apoptotic injuries.
    Cook JL; Routes JM
    Front Biosci; 2005 May; 10():1396-414. PubMed ID: 15769634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of NKG2D/NKG2D ligand interaction attenuated cardiac remodelling after myocardial infarction.
    Matsumoto K; Obana M; Kobayashi A; Kihara M; Shioi G; Miyagawa S; Maeda M; Sakata Y; Nakayama H; Sawa Y; Fujio Y
    Cardiovasc Res; 2019 Mar; 115(4):765-775. PubMed ID: 30307485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new role of protein phosphatase 2a in adenoviral E1A protein-mediated sensitization to anticancer drug-induced apoptosis in human breast cancer cells.
    Liao Y; Hung MC
    Cancer Res; 2004 Sep; 64(17):5938-42. PubMed ID: 15342371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo.
    Cook JL; Miura TA; Iklé DN; Lewis AM; Routes JM
    Cancer Res; 2003 Jun; 63(12):3435-43. PubMed ID: 12810682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E1A oncogene expression level in sarcoma cells: an independent determinant of cytolytic susceptibility and tumor rejection.
    Cook JL; Wilson BA; Wolf LA; Walker TA
    Oncogene; 1993 Mar; 8(3):625-35. PubMed ID: 8437846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of tumor necrosis factor-alpha in E1A oncogene-induced susceptibility of neoplastic cells to lysis by natural killer cells and activated macrophages.
    Cook JL; May DL; Wilson BA; Holskin B; Chen MJ; Shalloway D; Walker TA
    J Immunol; 1989 Jun; 142(12):4527-34. PubMed ID: 2723438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.
    Hayakawa Y; Kelly JM; Westwood JA; Darcy PK; Diefenbach A; Raulet D; Smyth MJ
    J Immunol; 2002 Nov; 169(10):5377-81. PubMed ID: 12421908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncogene-dependent apoptosis is mediated by caspase-9.
    Fearnhead HO; Rodriguez J; Govek EE; Guo W; Kobayashi R; Hannon G; Lazebnik YA
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13664-9. PubMed ID: 9811857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E1A inhibition of radiation-induced NF-kappaB activity through suppression of IKK activity and IkappaB degradation, independent of Akt activation.
    Shao R; Tsai EM; Wei K; von Lindern R; Chen YH; Makino K; Hung MC
    Cancer Res; 2001 Oct; 61(20):7413-6. PubMed ID: 11606372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.
    Lodoen M; Ogasawara K; Hamerman JA; Arase H; Houchins JP; Mocarski ES; Lanier LL
    J Exp Med; 2003 May; 197(10):1245-53. PubMed ID: 12756263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents.
    Stiewe T; Parssanedjad K; Esche H; Opalka B; Pützer BM
    Cancer Res; 2000 Jul; 60(14):3957-64. PubMed ID: 10919674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LIGHT/IFN-γ triggers β cells apoptosis via NF-κB/Bcl2-dependent mitochondrial pathway.
    Zheng QY; Cao ZH; Hu XB; Li GQ; Dong SF; Xu GL; Zhang KQ
    J Cell Mol Med; 2016 Oct; 20(10):1861-71. PubMed ID: 27241100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential survival of γδT cells, αβT cells and NK cells upon engagement of NKG2D by NKG2DL-expressing leukemic cells.
    Poggi A; Zancolli M; Boero S; Catellani S; Musso A; Zocchi MR
    Int J Cancer; 2011 Jul; 129(2):387-96. PubMed ID: 20853320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutting edge: the AP-1 subunit JunB determines NK cell-mediated target cell killing by regulation of the NKG2D-ligand RAE-1epsilon.
    Nausch N; Florin L; Hartenstein B; Angel P; Schorpp-Kistner M; Cerwenka A
    J Immunol; 2006 Jan; 176(1):7-11. PubMed ID: 16365389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delivery of NKG2D ligand using an anti-HER2 antibody-NKG2D ligand fusion protein results in an enhanced innate and adaptive antitumor response.
    Cho HM; Rosenblatt JD; Tolba K; Shin SJ; Shin DS; Calfa C; Zhang Y; Shin SU
    Cancer Res; 2010 Dec; 70(24):10121-30. PubMed ID: 21159634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interaction of adenovirus E1A with p300 family members modulates cellular gene expression to reduce tumorigenicity.
    Miura TA; Cook JL; Potter TA; Ryan S; Routes JM
    J Cell Biochem; 2007 Mar; 100(4):929-40. PubMed ID: 17063489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E1A second exon requirements for induction of target cell susceptibility to lysis by natural killer cells: implications for the mechanism of action.
    Krantz CK; Routes BA; Quinlan MP; Cook JL
    Virology; 1996 Mar; 217(1):23-32. PubMed ID: 8599207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenovirus E1A inhibits IFN-induced resistance to cytolysis by natural killer cells.
    Routes JM
    J Immunol; 1993 May; 150(10):4315-22. PubMed ID: 7683316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase.
    Boulakia CA; Chen G; Ng FW; Teodoro JG; Branton PE; Nicholson DW; Poirier GG; Shore GC
    Oncogene; 1996 Feb; 12(3):529-35. PubMed ID: 8637709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.